People
Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards.
Changes announced to executive team to accelerate growth and strategy
Crescendo Biologics Ltd today announces that Pavel Pisa, MD, PhD, has been appointed as Chief Medical Officer of the Company with immediate effect.
Danforth Advisors, LLC today announced additional regional leadership and support with the appointment of Robert Dickey IV as Managing Director, Mid Atlantic Region.
IDBS, a leader in enterprise scientific informatics platforms, today announced that Christian Marcazzo has joined the company as Vice President and General Manager, effective immediately.
DefiniGEN today announces the appointment of Professor Sir John Savill as a Non-Executive Director of the Board.
Macrophage Pharma Limited announced today the formation of an international Scientific Advisory Board (SAB).
EpicGenetics and Massachusetts General Hospital (MGH) are launching a Phase II clinical trial to test a tuberculosis vaccine, BCG, as a potential treatment for fibromyalgia.
José Baselga, chief medical officer at Memorial Sloan Kettering Cancer Center came under fire this weekend for his failure to disclose financial ties to various pharmaceutical companies when he published research papers in peer-reviewed journals.
The opposition to Takeda Pharmaceutical acquiring Shire has taken on another dimension with a prominent member of the family that created the Japanese pharmaceutical company speaking publicly against the deal.
PRESS RELEASES